Dimethyl fumarate Accord Unió Europea - islandès - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dímetýl fúmarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Elvanse Adult Hart hylki 30 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 30 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 30 mg

Elvanse Adult Hart hylki 50 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 50 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 50 mg

Elvanse Adult Hart hylki 70 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 70 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 70 mg

Elvanse Adult Hart hylki 20 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 20 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 20 mg

Elvanse Adult Hart hylki 40 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 40 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 40 mg

Elvanse Adult Hart hylki 60 mg Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

elvanse adult hart hylki 60 mg

takeda pharmaceuticals international ag ireland branch - lisdexamfetaminum dimesylate - hart hylki - 60 mg

Natpar Unió Europea - islandès - EMA (European Medicines Agency)

natpar

takeda pharmaceuticals international ag ireland branch - skjaldkirtilshormón - hypoparateyroidism - kalsíumsterastasis - natpar er ætlað sem viðbótarmeðferð hjá fullorðnum sjúklingum með langvarandi ofsabjúgshjúp, sem ekki er hægt að stjórna með nægilegum hætti með venjulegri meðferð einu sér.

Marcain adrenalin Stungulyf, lausn 2,5 mg/ml+5 míkróg/m Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

marcain adrenalin stungulyf, lausn 2,5 mg/ml+5 míkróg/m

aspen pharma trading limited - bupivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 2,5 mg/ml+5 míkróg/m

Marcain adrenalin Stungulyf, lausn 5 mg/ml+5 míkróg/ml Islàndia - islandès - LYFJASTOFNUN (Icelandic Medicines Agency)

marcain adrenalin stungulyf, lausn 5 mg/ml+5 míkróg/ml

aspen pharma trading limited - bupivacainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 5 mg/ml+5 míkróg/ml